SightGlass Vision Shares Latest Diffusion Optics Technology™Data at ARVO 2024, Affirming Myopia Management Performance

Myopia management innovator SightGlass Vision will present new data surrounding its Diffusion Optics Technology^™(DOT 0.2) spectacle lenses from four studies at the ARVO 2024 Annual Meeting, which will draw thousands of eye and vision scientists to Seattle from May 5-9. The collective scientific body of knowledge deepens support for DOT™ spectacle lenses’ efficacy, safety, mechanism of action, and positive patient experience.

The company’s flagship myopia control intervention uses thousands of light scattering elements to mimic more natural contrast on the retina—a unique mechanism of action to slow myopia progression in children.

Building on its long-term CYPRESS trial, SightGlass Vision initiated CATHAY—a two-year, randomized, controlled clinical trial of children ages 6 to 13 across five sites in China. Control of Myopia Using Diffusion Optics Technology (DOT) Spectacle Lenses in a Chinese Population (Laughton D, et al) analyzes 71 participants at the six-month mark, indicating that DOT lenses substantially slowed myopia progression, as measured by cycloplegic spherical equivalent refraction (cSER) and axial length (AL), compared to the standard single vision spectacle lens control group.

AL increased from baseline by 0.19 mm (p <0.001) in the control compared to -0.05 mm (p=0.04) among DOT lens wearers. cSER increased from baseline by -0.38D (p<0.0001) among the control versus by 0.01D (p=0.85) with the DOT group. Unadjusted mean differences in the changes from baseline were significant: -0.23 mm for AL and 0.39D for cSER.

“The CATHAY interim results further validate the findings from our multi-year CYPRESS study, supporting the hypothesis that modulating retinal contrast can slow myopia progression in children from diverse populations.”

Debbie Laughton, BSc, PhD, Director of Medical Affairs for SightGlass Vision

Short Term Effect of DOT Spectacle Lenses on Choroidal Thickness in Emmetropic Children (Jabeen A, et al) illustrates the macula choroidal thickening (ChT) in children following short-term DOT spectacle lens wear, similar or greater to response from +3.00D spectacle lens use—a positive indication that contrast reduction favorably affects this uveal tract tissue. Conducted by the Centre for Ocular Research & Education (CORE), the research enrolled 30 children ages 8 to 14 in a two-visit, prospective, randomized, subject-masked crossover study.

Treatment Zone Visual Acuity with Myopia Control Spectacle Lenses (Rani R, et al) profiles the immediate effect of Diffusion Optics Technology (DOT), Defocus Incorporated Multiple Segments (DIMS), and Highly Aspherical Lenslets (HAL) interventions on high- and low-contrast foveal visual acuity (VA). Investigators from Aston University’s Optometry & Vision Science Research Group enrolled 20 myopia adults in the prospective, single-visit, double-blind, four-way randomized crossover study to compare the technologies to single vision plano spectacle lenses. All three myopia management technologies performed well against the single vision lens, with DOT lenses providing superior VA in the peripheral treatment zone.

Aston researchers are also presenting findings from The Short-Term Effects of Spectacle-Based Myopia Management Interventions on Dynamic Vision (Davis L, et al), which used the same group of participants. Dynamic vision when wearing DOT, DIMS, or HAL spectacle lenses was noted as good and generally similar to the single vision control.

SightGlass boy wearing glasses with his family in the back

“Our scientific program at ARVO 2024 adds to the substantial evidence supporting the myopia control efficacy of Diffusion Optics Technology, as well as guiding eye care professionals on making more informed choices regarding spectacle lens interventions. We are enthusiastic about how DOT lenses have been received in multiple countries and remain excited by the prospect of reaching even more children around the world.”

Andrew Sedgwick, CEO, SightGlass Vision

SightGlass Vision’s patent-protected technology with clinically proven efficacy [1],[2],[3],[4] has made its commercial debut in several markets, including China, the Netherlands, and Israel, as well as through preliminary market trials in other countries. The company operates as a joint venture of CooperCompanies and EssilorLuxottica.

For more information, visit SightGlassVision.com.

^[1] Chalberg T., et al. Control of Myopia Using Diffusion Optics Spectacle Lenses: Efficacy and Safety Study (CYPRESS) 42-month results. ARVO 2023 Annual Meeting presentation. 27 April 2023.

^[2] Control of myopia using Diffusion Optics Technology™ spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS). British Journal of Ophthalmology Published Online First: 01 September 2022. DOI: 10.1136/bjo-2021-321005

^[3] Rappon J., et al. Two-year effectiveness of a novel myopia management spectacle lens with full-time WEARERS. Invest. Ophthalmol. Vis. Sci. 2022;63(7):408.

^[4] Laughton, D et al. Safety and Efficacy of a Novel Spectacle Lens for Myopia Control Over Three Years. 2022 American Academy of Optometry annual meeting. 27 Oct 2022.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

May 1, 2024March 25, 2024

Lool Eyewear Introduces New Collection for Deco Series

Voila Optik March-April 2024 lool Altair

lool eyewear launches its SS24 collection, from the Deco Series. Inspired by art deco from minimalism, this collection expresses itself in noble metal finishes. The luxury finishes take the spotlight in the six new models: the Deco Series frames are meticulously hand-painted
one by one with high quality decorative lacquers for a unique and sophisticated finish.

Featured model: Altair

Distributed by: www.looleyewear.com

About lool eyewear:

A project that was born trying to create the best screwless hinge.

Since its inception, lool has recognized itself as a multidisciplinary design studio where different profiles collaborate with a common goal. Once we meet our goal of creating the best screwless hinge, we focus on designing and producing creative frames that are functional and lightweight.

lool is a multidisciplinary creative studio based in Barcelona. Our team is born from the mixture of different disciplines such as advertising, branding, design, fashion and journalism, which allows us to have a unique and fresh vision in the field of optics.

May 1, 2024April 30, 2024

Essilor Stellest Lenses Now Available in Sun Tints and an Extended Range

Essilor® announces the launch of its new Stellest® lenses with sun tints, available in Canada starting May 7, 2024. The new sun tints provide children and teenagers with the option to continue to wear Essilor® Stellest® lenses for outdoor activities, offering protection from sunlight. Alongside this launch, the company also announced that the Essilor® Stellest® lens, the clear spectacle lens for myopia management, will be available in a wider prescription range globally, to meet the needs of more myopic children and teenagers.

Essilor® Stellest® Lenses with Sun Tints

EssilorLuxottica has developed Essilor® Stellest® lenses with sun tints, to provide children and teenagers with the opportunity to continue to wear the spectacle lenses with protection from sunlight and increased vision comfort, so they can enjoy more time outdoors, without compromising their eyesight.

The Essilor® Stellest® lens two-year clinical trial results show that there is greater efficacy when the lenses are worn more than 12 hours per day, *^1,2 The lenses will be available in several vibrant colours, and this tint selection gives the wearer a greater pairing choice when choosing frames. Essilor® Stellest® lenses with sun tints will also come with a Crizal Sun XProtect coating, an all-new protective coating that is two times stronger at protecting against scratches and smudges.

Essilor® Stellest® Lenses Extended Range

EssilorLuxottica will also launch the Essilor® Stellest® lenses extended range, which aims to meet the needs of more myopic children and teenagers. The extended range is for the clear spectacle lenses, catering for patients with a myopic spherical equivalent refractive error (SER).

See below for more details on the new range. ^§ The rest of the features of the lens remain the same and the extended range applies only for the clear spectacle lens for myopia management.

SPH: [+2.00^¶; -12.00]
CYL: [0.00; -4.00], depending on sphere
^¶SER ≤0 for sphere [0.00; +2.00]

“We are pleased to announce the launch of our new Essilor® Stellest® lenses with sun tints so that children and teenagers can continue to enjoy the benefits of outdoor time and protect their eyes from sunlight. The idea of encouraging children to spend time outdoors has already been widely accepted within the myopia community. So, with this new option, we hope that children will continue to wear their Essilor® Stellest® lenses outdoors, as it is necessary to safeguard their developing eyes, and help protect their vision for the future. In addition, our extended range will help equip and address a larger myopic population of children and teenagers.”

Norbert Gorny, Chief Scientific Officer at EssilorLuxottica.

Essilor® Stellest® lenses slow myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours per day, every day. ^†1

Essilor® Stellest® sun tints will be available in Canada on May 7, 2024.

Click HERE for the full press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

Footnote3

CYL, cylinder; H.A.L.T., Highly Aspherical Lenslet Target; SER, Spherical Equivalent Refraction; SPH, sphere

*Two-year prospective, controlled, randomized, double-masked clinical trial results on 54 myopic children wearing Essilor® Stellest® lenses compared to 50 myopic children wearing single vision lenses in Wenzhou China

^†Two-year prospective, controlled, randomized, double-masked clinical trial results on 54 myopic children wearing Essilor® Stellest® lenses compared to 50 myopic children wearing single vision lenses in Wenzhou China. Results based on 32 children from the Test Group wearing Essilor® Stellest® lenses at least 12 hours per day every day for two consecutive years

^§Subject to the prescription provided by prescribing eye care professionals, the products are technically available for a wider power range of SER (SER≤ 0 D).

^¶SER ≤0 for sphere [0.00; +2.00]

Bao J et al. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA ophthalmology. 2022;140(5):472-8
Drobe B. et al., Influence of wearing time on myopia control efficacy of spectacle lenses with aspherical lenslets. Investigative Ophthalmology & Visual Science. 2022 Jun 1;63(7):4324-A0029
Source: Euromonitor, Eyewear 2023 edition; Essilor International company; worldwide retail value sales at RSP.
Quantitative research conducted among a representative sample of 958 independent ECPs by CSA in February 2019 – France, the UK, Germany, Italy, Spain, the US, Canada, Brazil, China, India.

April 30, 2024April 30, 2024

WCO and CooperVision Partner on Myopia Management Navigator Educational Resource

World Council of Optometry and CooperVision logos

To help advance myopia management as a standard of care, the World Council of Optometry (WCO) is partnering with CooperVision to introduce an interactive and educational resource for eye care practitioners worldwide. The WCO CooperVision^®Myopia Management Navigator (myopianavigator.info) takes you on a journey through the three M’s of myopia management: mitigation, measurement, and management.

WCO Coopervision Myopia Management Navigator

Each of the three sections of the Navigator is linked to various elements of content and filled with advice and practical actions to explore in the form of “Myopia Moments,” webinars and much more. The Navigator also serves as a ready resource in clinical settings to provide guidance for patients and families in discussions about myopia management.

“We are pleased to partner with CooperVision on this important educational initiative which complements our ongoing efforts to advance myopia management as the global standard of care. It is crucial to educate both new and more experienced practitioners, and to expand their knowledge on integrating myopia management in their practices. We have made good progress, but there is still work to be done to prompt action worldwide.”

Dr. Sandra Block, WCO President

The WCO myopia management standard of care resolution was developed and introduced in April 2021. It includes the three main standard of care pillars of mitigation, measurement, and management. With the global support of CooperVision, WCO has since worked to advance awareness and adoption of this landmark initiative.

CooperVision Director, Global Professional Affairs, Myopia Elizabeth Lumb said, “The Navigator offers a user-friendly online platform, providing a simple and accessible resource for clinicians, parents, and allied professionals to navigate their own educational path through myopia management. In addition, we’re grateful to the WCO for offering an opportunity to partner with global ambassadors, enabling us to extend our reach and raise awareness on a global scale. This collaboration provides us with an extra avenue to amplify and promote this valuable resource.”

WCO recently appointed a team of ambassadors to spread the word about the Navigator based on their myopia management educational roles, outreach, and practice-building initiatives. One ambassador serves as a global representative, and the remaining three regional leads from a diverse set of geographies are leading optometrists with extensive experience in myopia management in both clinical practice and educational settings. All four WCO ambassadors are actively involved in day-to-day myopia management.

They are:

Nicola Logan, PhD, MEd, MCOptom, SFHEA, FBCLA, Global Representative: Nicola Logan is a professor of optometry and physiological optics at the School of Optometry at Aston University in Birmingham, United Kingdom.

Jagrut Lallu, MSc Specialty Lenses, BOptom, FIAOMC, Asia–Pacific Representative: Jagrut Lallu is a partner of Rose Optometry in Hamilton, New Zealand. He is also the director of Innovatus Technology, which develops software to make contact lens design accessible to contact lens practitioners.

Síofra Harrington, PhD, FAOI, European Representative: Síofra Harrington is a lecturer, researcher, and clinical supervisor with the School of Physics, Clinical and Optometric Sciences at Technological University in Dublin, Ireland. She is also a fellow of the Association of Optometrists Ireland.

Ashley Wallace Tucker, OD, FAAO, FSLS, ABO Diplomate, Americas Representative: Ashley Wallace Tucker is a partner at Bellaire Family Eye Care and The Contact Lens Institute of Houston, a private practice in Houston, Texas. Tucker is also a visiting assistant professor at the University of Houston College of Optometry, where she is the course master for the Ophthalmic Optics Laboratory.

For global ambassador full biographies, click here.

To access the WCO CooperVision^® Myopia Management Navigator, visit myopianavigator.info. Explore the World Council of Optometry myopia management online resource featuring the standard of care pledge signup page, resolution, and practical tools and information for optometrists at https://myopia.worldcouncilofoptometry.info/. For questions about myopia management, email the WCO ambassadors at MMNambassador@worldoptometry.org.

Click HERE for the press release.

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!

April 30, 2024April 30, 2024

New Research Report Highlights Actions to Attract Potential & Former Contact Lens Patients

The Contact Lens Institute (CLI) has published an in-depth report on everyday actions that the eye care community can take to draw interest from potential and former contact lens wearers. Based on research with more than 1,000 vision-corrected adults segmented by glasses-only wearers, new contact lens wearers, and contact lens dropouts, “Beyond Vision: Behaviors to Attract New & Returning Contact Lens Wearers” is the latest offering from CLI’s See Tomorrow initiative, which helps practices thrive using exclusive consumer data and insights.

The 26-page document includes multiple infographics depicting high value takeaways, which are ideal for staff training. Another 19 quick take columns and bulleted checklists offer practical implementation tips, all of which were contributed by 2024 CLI Visionaries. The report is available for download or online reading at https://www.contactlensinstitute.org/resources/see-tomorrow/.

“With 47.8% of glasses wearers indicating a high interest in trying contact lenses, and lapsed contact lens wearers signaling what would motivate them to resume use, the tremendous untapped potential for the category is unmistakable. Our research found specific areas of consumer excitement, concern, and misperception that eye care practices can leverage to aid more efficient and effective contact lens conversations among likely candidates. Better yet, these aspects can be reinforced easily and quickly across the entire patient experience, from appointment scheduling to the exam to follow-up, by every member of the practice team.”

Stan Rogaski, CLI executive director

Highlights explored within the “Beyond Vision” report include:

Sources of contact lens influence, led by optometrists and ophthalmologists (66% of glasses wearers / 46% of new contact lens wearers), opticians (44% of glasses wearers / 26% of new contact lens wearers), and friends and family (40% of glasses wearers, 31% of new contact lens wearers).

A ranking of 25 factors that would aid potential wearers’ consideration of contacts, with an eye doctor explaining why contacts can benefit a patient placing first (66%). Other aspects that practice teams may take for granted were also evident, such as understanding insertion and removal (52%), taking trial lenses home (51%), and knowing about the range of price and performance options (47%).

Primary motivators for initial contact lens trial among new wearers, who called out freedom from glasses (44%), personal appearance (42%), and ease of use (39%) as the most significant.
A review of which contact lens advancements spark the most excitement, with toric designs (46%) and UV protection (43%) cited most by potential wearers, and contacts for digital device use and UV protection tied for the highest spot (64%) by new contact lens wearers.

Practice behaviors that detract from contact lens trial, including a lack of exam staff raising the subject, not alerting patients they were candidates, and not providing contact lens information—all cited by about 20% of glasses-only respondents.

Additional non-behavioral issues that dissuade trial, including fear factors such as patients not wanting to touch their eye (44%) and infection concerns (25%); affordability (30%); and misperceptions that having dry eye (27%) and astigmatism (17%) prevent contact lens wear—most of which can be addressed through communication.

Ratings from former contact lens wearers of what would motivate them to return, split by those who dropped out within the past two years compared to longer-term dropouts. Among more recent dropouts, awareness of new advances (55%), a renewed conversation with their eye doctor about contact lens benefits (50%), dual/part-time wear alongside glasses (50%), and the availability of trial lenses (50%) were at the top. Those who abandoned wear longer ago placed the most weight on being made aware of contact lenses for a specific eye condition (85%), of new advances and technologies (74%), price and performance options (72%) and access to trial lenses (66%).

The additive value of having contact lens advocates throughout the practice, as up to 30% of glasses-only wearers reported that such enthusiasm would influence their decision to try contacts. When it comes to discussing the benefits of contact lenses, the research outcomes emphasized the importance of doctors personally having that conversation, versus fully delegating information sharing to their teams. For glasses wearers, the recommendation from the optometrist or ophthalmologist matters to 66% of them, compared to 22% for eye exam staff and 8% for eyewear display staff.

2024 CLI Visionaries who contributed to “Beyond Vision” are Monica Bhula, OD; Shelby Brogdon, OD; Andrew S. Bruce, LDO, ABOM, NCLEM, FCLSA; Jenn Seymour Brusven, LDO, NCLE-AC, ABO-AC, AAS; Ariel Cerenzie, OD, FAAO, FSLS; Angelica Cifuentes, OD; Jade Coats, OD; Jason Compton, OD, FAAO; Janelle Davison, OD; Sabrina Gaan, OD; Lisa Hornick, OD, MBA, FAAO; Diana Mejia; Scott Moscow, OD; Ashley O’Dwyer, OD; Shalu Pal, OD, FAAO, FSLS, FBCLA, FIAOMC; Adam Ramsey, OD; Noha Seif, OD, FAAO, FSLS; Dana Shannon, OD, FAAO; and Jennifer Tsai, OD.

The research was commissioned by the Contact Lens Institute and conducted by Prodege from February 1-9, 2024, via an online survey. Respondents included 1,053 vision-corrected adults ages 18-64 residing in the United States.